Consun Pharmaceutical Group Limited

1681

KYG2524A1031

Pharmaceuticals

Market Closed - Hong Kong S.E. Other stock markets 04:08:20 2024-04-26 am EDT			5-day change	1st Jan Change
5.67 ^HKD	-0.87%		+1.61%	+18.87%

Mar. 29	Consun Pharmaceutical Group Sees 15% Increase in 2023 Profit	MT
Mar. 28	Consun Pharmaceutical Group Limited Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 21 June 2024	CI

Consun Pharmaceutical Group Limited Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 21 June 2024

March 28, 2024 at 12:04 am EDT

Consun Pharmaceutical Group Limited proposed final dividend for the year ended 31 December 2023 of HKD 0.3 per share. The dividend will be payable on 21 June 2024 with Record date of 12 June 2024 and Ex-dividend date of 11 June 2024. Date of shareholders' approval on 31 May 2024.

Latest news about Consun Pharmaceutical Group Limited

Consun Pharmaceutical Group Sees 15% Increase in 2023 Profit	Mar. 29	MT
Consun Pharmaceutical Group Limited Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 21 June 2024	Mar. 28	CI
Consun Pharmaceutical Group Limited Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 28	CI
Consun Pharmaceutical Group Limited Announces Board and Committee Changes	Mar. 25	CI
Consun Pharma CEO Steps Down	Jan. 17	MT
Consun Pharmaceutical Group Limited Announces CEO Changes	Jan. 17	CI
Consun Pharmaceutical Group Limited Announces Management Changes	Jan. 17	CI
Consun Pharmaceutical's Unit Starts Construction of Second Chinese Medicine Granule Plant	23-10-26	MT
Consun Pharmaceutical's H1 Profit Rises on Higher Revenue	23-08-24	MT
Consun Pharmaceutical Group Limited Announces Interim Dividend for the Six Months Ended 30 June 2023, Payable on 20 September 2023	23-08-24	CI
Consun Pharmaceutical Group Limited Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-24	CI
Consun Pharmaceutical Group Limited Approves Final Dividend for the Year Ended 31 December 2022	23-05-31	CI
Consun Pharmaceutical Group Limited Declares Final Dividend for the Year Ended December 31, 2022	23-04-27	CI
Chinese Regulator Approves Consun Pharmaceutical's Clinical Trial for Kidney Disease Treatment	23-04-17	MT
Consun Pharmaceutical Group Limited Receives Approval for Clinical Trial of Drug for SK-07 Injection	23-04-16	CI
Consun Pharmaceutical Group Limited Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-23	CI
Consun Pharmaceutical Group Limited Proposes to Pay A Final Dividend for the Year Ended December 31, 2022, Payable on or About June 21, 2023	23-03-23	CI
Consun Pharmaceutical Group Sees Surge in 2022 First-Half Profit	22-09-23	MT
Consun Pharmaceutical's H1 Profit Rises on Higher Revenue	22-08-26	MT
Consun Pharmaceutical Group Limited Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-26	CI
Wanbangde Pharma in Talks to Buy Controlling Stake in Consun Pharma	22-07-26	MT
Consun Pharmaceutical Group Completes First Automatic Production Line of Chinese Medicine Granules	22-06-21	MT
Consun Pharmaceutical Group Limited, A Wholly-Owned Subsidiary of Consun Pharmaceutical Co., Ltd Holds A Trial Production Ceremony in Plant No. 8, Area A05, Horgos Comprehensive Bonded Zone, Yili Kazakh	22-06-20	CI
Consun Pharmaceutical Group Limited Approves Final Dividend for the Year Ended December 31, 2021	22-05-27	CI
Consun Pharmaceutical Group Limited Proposes Final Dividend for the Year Ended 31 December 2021, Payable on or About 17 June 2022	22-04-25	CI

Chart Consun Pharmaceutical Group Limited

Duration

Period

Chart Consun Pharmaceutical Group Limited

More charts

Company Profile

Consun Pharmaceutical Group Limited is an investment holding company principally engaged in the manufacture and sale of pharmaceuticals. The pharmaceutical products of the Company include kidney medicines, contrast medium and others. The Companyâs subsidiaries include Brilliant Reach Group Limited, Century International Develop Limited and Grand Reach Company Limited. Through its subsidiaries, the Company is also engaged in the research and development of pharmaceutical products.

Sector

Pharmaceuticals

Calendar

2024-08-21 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Consun Pharmaceutical Group Limited

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

5.249 CNY

Average target price

7.272 CNY

Spread / Average Target

+38.54%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
CONSUN PHARMACEUTICAL GROUP LIMITED	+18.87%	575M
SUN PHARMACEUTICAL INDUSTRIES LTD.	+19.62%	43.34B
OTSUKA HOLDINGS CO., LTD.	+20.44%	21.96B
SANDOZ GROUP AG	+10.86%	14.09B
CIPLA LIMITED	+13.07%	13.64B
ZYDUS LIFESCIENCES LIMITED	+37.46%	11.43B
ONO PHARMACEUTICAL CO., LTD.	-8.59%	6.86B
THE MEDICINES COMPANY	-0.05%	6.79B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+8.46%	5.22B

Generic Pharmaceuticals